Home Pharmacy
The treatment effects of early comprehensive disease-modifying pharmacological therapy are considerable for patients with heart failure with reduced ejection fraction

Disease-Modifying Drug Regimen May Offer Benefit in Heart Failure

Lower risk for cardiovascular death or hospital admission seen in HF with reduced ejection fraction
A total of 9.5 percent of persons were uninsured from January through June 2019

9.5 Percent Uninsured in U.S. From January Through June 2019

Overall, 13.7 percent of adults aged 18 to 64, 4.4 percent of children aged 0 to 17 were uninsured
Women with screening-detected ductal carcinoma in situ have increased long-term risks for invasive breast cancer and breast cancer death

Risk for Later Invasive Breast Cancer Up for Women With DCIS

Risks for invasive breast cancer, death from breast cancer higher for up to 20 years following diagnosis
Hydroxychloroquine and azithromycin may have a serious adverse impact on the cardiovascular system

CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine

Risk increased for prolonged QT and/or ventricular tachycardia, including torsades de pointes
Large pharmacy chains

Large U.S. Pharmacy Chains Played Role in Opioid Crisis, Lawsuit Claims

Lawsuit charges chains sold millions of pills in small communities, gave bonuses to pharmacists
Coronavirus antibody test results may not be accurate enough to help guide decisions about whether to allow large groups of people to gather at work

CDC: Coronavirus Antibody Tests Still Not Accurate Enough

Too little is known about what the presence of antibodies means in terms of future immunity
Patients initiating hemodialysis often are prescribed opioids and short-acting benzodiazepines

Benzodiazepines, Codispensed Opioids Common in Hemodialysis

Risk for mortality increased for those receiving short-acting benzodiazepines alone or with opioids
A recombinant adenovirus type-5 vectored COVID-19 vaccine is safe

Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise

ELISA antibodies and neutralizing antibodies increased at day 14, peaked at day 28
For patients with COVID-19 requiring hospitalization

Hydroxychloroquine Plus Macrolides No Benefit in COVID-19

Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
For adults hospitalized with COVID-19 with lower respiratory tract infection

Remdesivir Beats Placebo for Time to COVID-19 Recovery

Researchers suggest antiviral agents in combination with other therapeutic approaches may further improve outcomes